Find Clinical Trials
Dose ranging study of S 44497 administered orally once daily for four weeks in type 2 diabetic patients. A multicentre, randomised, double-blind, double-dummy, phase II study versus placebo and glimepiride and sitagliptin.
Servier Protocol Code:
CL2-44497-004
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2007-003808-35
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Diabetes - Type II
- S044497
Other study id numbers
Other identification numbers the study may be known by.
- CL2-44497-004